Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors 2023-12-11 20:00
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results 2023-12-11 18:55
Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib 2023-12-11 13:30
Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3% 2023-12-11 13:14
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery 2023-12-11 09:00
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH 2023-12-10 18:00
PharmaBlock Officially Joins United Nations Global Compact 2023-12-08 12:37
Regor Announces Promising Safety And Single Agent Efficacy Data Evaluating RGT-419B In HR+/HER2- Advanced Breast Cancer Patients Who Have Progressed On CDK4/6 Inhibitors And Endocrine Therapy 2023-12-08 07:39
2023 SABCS - TransThera announces an oral presentation of tinengotinib clinical data in breast cancer 2023-12-07 21:00
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant 2023-12-06 22:30
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader 2023-12-06 17:00
Results of three investigator-initiated trials on cadonilimab (PD-1/CTLA-4) for G/GEJC, pMMR/MSS mCRC, and HCC neoadjuvant therapy published at ESMO Asia 2023 2023-12-05 21:00
J INTS BIO Gives Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, at ESMO Asia 2023 2023-12-05 15:16
CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia 2023-12-04 21:50
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis 2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck 2023-12-04 21:05
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS 2023-12-04 21:00
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
Registrational Phase III CLARIFY trial in prostate cancer commences 2023-11-30 22:16
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level 2023-11-30 21:59
1 30 31 32 33 34 165